Valence ロゴ
人気
ログイン
Loading data for LFMDP — first visit, this takes a few seconds.

ウォッチリストに追加

LifeMD Inc.

NasdaqGM: LFMDP · リアルタイム株価 · USD
23.15
+0.00 (0.00%)
終値時点： Aug 27, 2026, 8:00 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

LifeMD Inc.（LFMDP）の株価・分析・データ

0.00%

データがありません

買気配23.45
時価総額n/a
売上高（TTM）191.59M
純利益（TTM）-24.87M
2.06
-2.26
n/a
n/a
PBR（TTM）139.32
PSR（TTM）n/a
決算発表日n/a
売気配24
出来高101
平均出来高（20日）2,204
始値23.15
前日終値23.15
当日レンジ23.15 - 23.15
52週レンジ18.50 - 24.20
アナリストn/a
目標株価n/a
配当$2.22 (9.53%)
権利落ち日2026年7月2日

LFMDPについて

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and p...

[続きを読む]
業種 Health Information Services
セクター Healthcare
IPO日 Oct 5, 2021
従業員数 347
上場取引所 NasdaqGM
ティッカー LFMDP
ウェブサイト https://lifemd.com
企業情報の全文

業績

2025年のLifeMDの売上高は194.06Mで、前年の154.82Mから25.34%の増加でした。 利益は14.35Mで、-167.05%の減少でした。

財務諸表
news image

2週間前 · Motley Fool

LifeMD (LFMD) Q2 2026 Earnings Call Transcript

Revenue met guidance but profitability targets missed amid strategic restructuring.

news image

3週間前 · Moby

LifeMD, Inc. Q2 2026 Earnings Call Summary

Moby summary of LifeMD, Inc.'s Q2 2026 earnings call

news image

3週間前 · MarketBeat

LifeMD Q2 Earnings Call Highlights

LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer acquisi...

news image

3週間前 · Zacks

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

LifeMD (LFMD) delivered earnings and revenue surprises of +20.00% and -3.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

3週間前 · MarketBeat

Medifast Q2 Earnings Call Highlights

Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medica...

2ページ中1ページ